Protara Therapeutics Stock Target Price and Analyst Consensus
| TARA Stock | USD 4.55 0.08 1.73% |
The current analyst and expert consensus on Protara Therapeutics is Strong Buy, with 3 strong buy opinions. The current projected Protara Therapeutics target price consensus is 28.00 with 4 analyst opinions. Check out Macroaxis Advice on Protara Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Protara Stock refer to our How to Trade Protara Stock guide.The most common way Protara Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Protara Therapeutics executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Protara Therapeutics. We encourage you to use your own analysis of Protara Therapeutics to validate this buy or sell advice. Protara Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Protara Therapeutics target price to derive its highest and lowest estimates based on projected price volatility of 10.9284.
Lowest Forecast 25.48 | Highest Forecast 31.08 | Target Price 28 |
Protara |
It's important to approach Protara Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Protara Therapeutics Target Price Consensus
Protara target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Protara Therapeutics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 4 | Strong Buy |
Most Protara analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Protara stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Protara Therapeutics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationProtara Therapeutics Target Price Projection
Protara Therapeutics' current and average target prices are 4.55 and 28.00, respectively. The current price of Protara Therapeutics is the price at which Protara Therapeutics is currently trading. On the other hand, Protara Therapeutics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Protara Therapeutics Market Quote on 19th of January 2025
Target Price
Analyst Consensus On Protara Therapeutics Target Price
Protara Therapeutics Analyst Ratings
Protara Therapeutics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Protara Therapeutics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Protara Therapeutics' financials, market performance, and future outlook by experienced professionals. Protara Therapeutics' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Protara Therapeutics price targets
Protara Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Protara Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Protara Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Protara Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Protara Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Protara Therapeutics is a key component of Protara Therapeutics valuation and have some predictive power on the future returns of a Protara Therapeutics.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | USD Crypto Fund Invested less than 1 share | |
 | Macroaxis Index Invested over 10K shares | |
 | Manufacturing Invested over 40 shares | |
 | Warren Buffett Holdings Invested over 40 shares |
Check out Macroaxis Advice on Protara Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Protara Stock refer to our How to Trade Protara Stock guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Please note, the presentation of Protara Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Protara Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Protara Therapeutics' management manipulating its earnings.